LCMS Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL - Part 4 - Multiplex Analysis -

Applications | 2017 | ShimadzuInstrumentation

LC/MS, LC/MS/MS, LC/QQQ

Industries

Clinical Research

Manufacturer

Shimadzu

Go to the library View PDF

Downloadable PDF for viewing

Similar PDF

LCMS Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL - Part 4 - Multiplex Analysis -

2017|Shimadzu|Applications

LAAN-A-LM-E119A Application News No. C148A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using FabSelective Proteolysis nSMOL - Part 4 - Multiplex Analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that…

Key words

multiplex, antibody, structure, nsmol, confirmation, quantitation, brentuximab, cetuximab, rituximab, drugs, mrm, nsmoltm, vedotin, analysis, plasma

Shimadzu Solutions for Biopharmaceutical - Application Notebook

2018|Shimadzu|Guides

C10G-E054 Solutions for Biopharmaceutical Application Notebook First Edition: December, 2017 © Shimadzu Corporation, 2017 Solutions for Biopharmaceutical Index Application Notebook Bioanalysis LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis nSMOL, which enables selective proteolysis of the…